BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 1524989)

  • 1. Studies of the RB1 gene and the p53 gene in human osteosarcomas.
    Scholz RB; Kabisch H; Weber B; Röser K; Delling G; Winkler K
    Pediatr Hematol Oncol; 1992; 9(2):125-37. PubMed ID: 1524989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P53 gene abnormalities in osteosarcoma.
    Guo W; Wang X; Feng C
    Chin Med J (Engl); 1996 Oct; 109(10):752-5. PubMed ID: 9275350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations of the retinoblastoma gene in human prostate adenocarcinoma.
    Tricoli JV; Gumerlock PH; Yao JL; Chi SG; D'Souza SA; Nestok BR; deVere White RW
    Genes Chromosomes Cancer; 1996 Feb; 15(2):108-14. PubMed ID: 8834174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [p53 antioncogene abnormal in osteosarcoma].
    Guo W; Wang SW; Feng CH
    Zhonghua Wai Ke Za Zhi; 1994 Jul; 32(7):412-5. PubMed ID: 7842979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of heterozygosity of the Rb gene correlates with pRb protein expression and associates with p53 alteration in human esophageal cancer.
    Xing EP; Yang GY; Wang LD; Shi ST; Yang CS
    Clin Cancer Res; 1999 May; 5(5):1231-40. PubMed ID: 10353761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of oncogene, tumor suppressor gene, and chromosomal alterations in HeLa x osteosarcoma somatic cell hybrids.
    Isfort RJ; Cody DB; Lovell GJ; Gioeli D; Weissman BE; Doersen CJ
    Mol Carcinog; 1999 May; 25(1):30-41. PubMed ID: 10331742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency and structure of p53 rearrangements in human osteosarcoma.
    Miller CW; Aslo A; Tsay C; Slamon D; Ishizaki K; Toguchida J; Yamamuro T; Lampkin B; Koeffler HP
    Cancer Res; 1990 Dec; 50(24):7950-4. PubMed ID: 2253237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation of the p53 gene in human soft tissue sarcomas: association with abnormalities of the RB1 gene.
    Stratton MR; Moss S; Warren W; Patterson H; Clark J; Fisher C; Fletcher CD; Ball A; Thomas M; Gusterson BA
    Oncogene; 1990 Sep; 5(9):1297-301. PubMed ID: 2216456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation spectrum of p53 gene in highly malignant human osteosarcomas.
    Radig K; Schneider-Stock R; Oda Y; Neumann W; Mittler U; Roessner A
    Gen Diagn Pathol; 1996 Jun; 142(1):25-32. PubMed ID: 8793483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Molecular analysis of tumor suppressor genes p16INK4 and TP53 of osteosarcomas in Spanish children].
    Patiño García A; Sierrasesúmaga Ariznabarreta L
    An Esp Pediatr; 1997 Nov; 47(5):478-82. PubMed ID: 9586287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular genetic considerations in osteosarcoma.
    Hansen MF
    Clin Orthop Relat Res; 1991 Sep; (270):237-46. PubMed ID: 1679382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of the retinoblastoma gene in primary osteosarcomas and other bone and soft-tissue tumors.
    Araki N; Uchida A; Kimura T; Yoshikawa H; Aoki Y; Ueda T; Takai S; Miki T; Ono K
    Clin Orthop Relat Res; 1991 Sep; (270):271-7. PubMed ID: 1884549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation spectrum of the p53 gene in bone and soft tissue sarcomas.
    Toguchida J; Yamaguchi T; Ritchie B; Beauchamp RL; Dayton SH; Herrera GE; Yamamuro T; Kotoura Y; Sasaki MS; Little JB
    Cancer Res; 1992 Nov; 52(22):6194-9. PubMed ID: 1423262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular and immunochemical analyses of RB1 and cyclin D1 in human ductal pancreatic carcinomas and cell lines.
    Huang L; Lang D; Geradts J; Obara T; Klein-Szanto AJ; Lynch HT; Ruggeri BA
    Mol Carcinog; 1996 Feb; 15(2):85-95. PubMed ID: 8599583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 gene gets altered by various mechanisms: studies in childhood sarcomas and retinoblastoma.
    Ghule P; Kadam PA; Jambhekar N; Bamne M; Pai S; Nair C; Banavali S; Puri A; Agarwal M
    Med Sci Monit; 2006 Dec; 12(12):BR385-396. PubMed ID: 17136003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered messenger RNA and unique mutational profiles of p53 and Rb in human esophageal carcinomas.
    Huang Y; Meltzer SJ; Yin J; Tong Y; Chang EH; Srivastava S; McDaniel T; Boynton RF; Zou ZQ
    Cancer Res; 1993 Apr; 53(8):1889-94. PubMed ID: 8467510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of a metastasizing testicular mixed gonadal stromal tumor with osteosarcoma components suggests that a malignant tumor with the histology of osteosarcoma may develop without primary involvement of RB1 and TP53.
    Reuvekamp PT; Stulp RP; Schraffordt Koops H; Oosterhuis JW; Scheffer H; Buys CH
    Cancer Res; 1992 Dec; 52(23):6705-7. PubMed ID: 1423318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional elucidation of MiR-34 in osteosarcoma cells and primary tumor samples.
    He C; Xiong J; Xu X; Lu W; Liu L; Xiao D; Wang D
    Biochem Biophys Res Commun; 2009 Oct; 388(1):35-40. PubMed ID: 19632201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue-specific expression of SV40 in tumors associated with the Li-Fraumeni syndrome.
    Malkin D; Chilton-MacNeill S; Meister LA; Sexsmith E; Diller L; Garcea RL
    Oncogene; 2001 Jul; 20(33):4441-9. PubMed ID: 11494139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integration of SV40 in human osteosarcoma DNA.
    Mendoza SM; Konishi T; Miller CW
    Oncogene; 1998 Nov; 17(19):2457-62. PubMed ID: 9824156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.